ONLY about half the $625 million drug companies are demanding from taxpayers for a cervical cancer vaccination program will go towards the program itself. The rest of the subsidy will go into the coffers of the two companies to cover marketing, the research and development that went into the vaccine — and profit. But the companies, CSL Limited and Merck, will not say how much of it will be profit.>>> Discuss This Story
